Structures by: Dunlap J. T.

Total: 5

Fluoxetine hydrochloride:fumaric acid cocrystal (2:1)

2(C17H19F3NO1Cl1),C4H4O4

Scott L. ChildsLeonard J. ChyallJeanette T. DunlapValeriya N. SmolenskayaBarbara C. StahlyG. Patrick Stahly

Journal of the American Chemical Society (2004) 126, 13335-13342

a=26.6914(8)Å   b=7.1807(3)Å   c=20.6546(7)Å

α=90.00°   β=90.00°   γ=90.00°

Fluoxetine hydrochloride:benzoic acid cocrystal (1:1)

(C17H19F3NO1,Cl1),C7H6O2

Scott L. ChildsLeonard J. ChyallJeanette T. DunlapValeriya N. SmolenskayaBarbara C. StahlyG. Patrick Stahly

Journal of the American Chemical Society (2004) 126, 13335-13342

a=14.806(5)Å   b=13.179(4)Å   c=24.417(7)Å

α=90.00°   β=97.738(13)°   γ=90.00°

Fluoxetine hydrochloride:succinic acid cocrystal (2:1)

2(C17H19F3NO1Cl1),C4H6O4

Scott L. ChildsLeonard J. ChyallJeanette T. DunlapValeriya N. SmolenskayaBarbara C. StahlyG. Patrick Stahly

Journal of the American Chemical Society (2004) 126, 13335-13342

a=26.620(2)Å   b=7.2147(7)Å   c=20.8315(19)Å

α=90.00°   β=90.00°   γ=90.00°

Metformin HCl form I

C4H12ClN5

Childs, Scott L.Chyall, Leonard J.Dunlap, Jeanette T.Coates, David A.Stahly, Barbara C.Stahly, G. Patrick

Crystal Growth & Design (2004) 4, 3 441

a=7.9231(12)Å   b=13.894(2)Å   c=7.9231(12)Å

α=90.00°   β=114.48°   γ=90.00°

Metformin HCl form II

C4H12ClN5

Childs, Scott L.Chyall, Leonard J.Dunlap, Jeanette T.Coates, David A.Stahly, Barbara C.Stahly, G. Patrick

Crystal Growth & Design (2004) 4, 3 441

a=7.6261(7)Å   b=6.1684(6)Å   c=18.1508(16)Å

α=90.00°   β=99.447(2)°   γ=90.00°